The Clorox Company (NYSE:CLX) Shares Acquired by Capital Analysts LLC

Capital Analysts LLC grew its stake in The Clorox Company (NYSE:CLX) by 39.8% during the first quarter, HoldingsChannel.com reports. The firm owned 710 shares of the company’s stock after purchasing an additional 202 shares during the period. Capital Analysts LLC’s holdings in The Clorox were worth $137,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. One Day In July LLC raised its stake in The Clorox by 3.3% during the first quarter. One Day In July LLC now owns 1,771 shares of the company’s stock worth $342,000 after acquiring an additional 57 shares during the period. Associated Banc Corp raised its stake in The Clorox by 4.5% during the first quarter. Associated Banc Corp now owns 1,330 shares of the company’s stock worth $230,000 after acquiring an additional 57 shares during the period. Venturi Wealth Management LLC raised its stake in The Clorox by 2.1% during the first quarter. Venturi Wealth Management LLC now owns 3,296 shares of the company’s stock worth $636,000 after acquiring an additional 67 shares during the period. Costello Asset Management INC raised its stake in The Clorox by 53.2% during the first quarter. Costello Asset Management INC now owns 193 shares of the company’s stock worth $37,000 after acquiring an additional 67 shares during the period. Finally, GPS Wealth Strategies Group LLC raised its stake in The Clorox by 2.6% during the first quarter. GPS Wealth Strategies Group LLC now owns 2,731 shares of the company’s stock worth $526,000 after acquiring an additional 69 shares during the period. Institutional investors and hedge funds own 77.62% of the company’s stock.

Shares of NYSE:CLX opened at $178.84 on Thursday. The company has a market capitalization of $22.24 billion, a PE ratio of 24.94, a price-to-earnings-growth ratio of 3.44 and a beta of 0.21. The Clorox Company has a 1-year low of $170.50 and a 1-year high of $239.87. The company has a quick ratio of 0.70, a current ratio of 1.08 and a debt-to-equity ratio of 2.65. The business’s 50 day simple moving average is $178.55.

The Clorox (NYSE:CLX) last issued its earnings results on Thursday, April 29th. The company reported $1.62 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.48 by $0.14. The firm had revenue of $1.78 billion during the quarter, compared to analysts’ expectations of $1.86 billion. The Clorox had a net margin of 12.27% and a return on equity of 104.74%. The firm’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period last year, the firm posted $1.89 earnings per share. As a group, research analysts predict that The Clorox Company will post 7.58 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, August 13th. Investors of record on Wednesday, July 28th will be given a $1.16 dividend. This represents a $4.64 annualized dividend and a dividend yield of 2.59%. The ex-dividend date is Tuesday, July 27th. This is an increase from The Clorox’s previous quarterly dividend of $1.11. The Clorox’s dividend payout ratio is 60.33%.

CLX has been the topic of several research reports. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of The Clorox from $195.00 to $186.00 and set a “hold” rating on the stock in a research note on Monday, May 3rd. Barclays restated a “sell” rating and issued a $162.00 target price on shares of The Clorox in a research report on Sunday, April 18th. Morgan Stanley decreased their target price on shares of The Clorox from $183.00 to $170.00 and set an “underweight” rating for the company in a research report on Monday, May 3rd. Jefferies Financial Group decreased their target price on shares of The Clorox from $205.00 to $195.00 and set a “hold” rating for the company in a research report on Tuesday, May 4th. Finally, Royal Bank of Canada restated a “neutral” rating on shares of The Clorox in a research report on Wednesday, May 5th. Four analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the company’s stock. The Clorox currently has an average rating of “Hold” and an average price target of $202.33.

The Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.

Featured Article: How to Use a Moving Average for TradingĀ 

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.